On September 16th, Simcere Pharma (02096) spent 1.2274 million Hong Kong dollars to repurchase 201,000 shares.
Sinopharm Pharmaceutical (02096) announced that the company will invest HK$1.2274 million on September 16, 2024...
SIMCERE PHARMA (02096) announced that on September 16, 2024, the company spent 1.2274 million Hong Kong dollars to repurchase 201,000 shares, with a repurchase price of 6.06-6.16 Hong Kong dollars per share.
Related Articles

New Stock Outlook | With the support of more than ten state-owned shareholders, can the merger and acquisition growth story of Tiandi HeXing earn market approval?

Guosen: The final mindset of asset trend convergence.

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
New Stock Outlook | With the support of more than ten state-owned shareholders, can the merger and acquisition growth story of Tiandi HeXing earn market approval?

Guosen: The final mindset of asset trend convergence.

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


